HiberCell Strengthens Leadership Team with Appointment of Colin Goddard to Board of Directors

NEW YORK, Aug. 6, 2019 /PRNewswire/ -- HiberCell , a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, today announced the appointment of Colin Goddard to the company's Board of Directors.